Causes and consequences of acidic ph in tumors: A magnetic resonance study

Advances in Enzyme Regulation

Volumn 39, Issue 1, 1999, Pages 13-30

  Stubbs, Marion ^a   McSheehy, Paul M J ^a   Griffiths, John R ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; LACTIC ACID; NUCLEOTIDE;

ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BIOLOGICAL MODEL; CANCER GRAFT; CELL MEMBRANE; CELL PH; CELL STRAIN HT29; CONFERENCE PAPER; CORRELATION FUNCTION; EXPERIMENTAL NEOPLASM; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; METABOLISM; MOUSE; NEOPLASM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUDE MOUSE; PH; PH MEASUREMENT; PROLACTINOMA; RAT; SOLID TUMOR; TISSUE METABOLISM;

EID: 0032883946     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-2571(98)00018-1     Document Type: Conference Paper

References (43)

1. O. WARBURG, The metabolism of tumours. Arnold Constable, London (1930).
2. E. HOLM, E. HAGMULLER, U. STAEDT, G. SCHLICKEISER, H-J. GUNTHER, H. LEWELING, M. TOKUS and H. B. KOLLMAR, Substrate balances across colonic carcinomas in humans, Cancer Res. 55, 1373-1378 (1995).
3. P. VAUPEL, F. KALLINOWSKI and P. OKUNIEFF, Blood flow, oxygen and nutrient supply, the metabolic microenvironment of human tumors: a review, Cancer Res. 49, 6449-6465 (1989).
4. J. R. GRIFFITHS, Are cancer cells acidic?, Brit. J. Cancer 64, 425-427 (1991).
5. M. STUBBS, Tumor pH: Blood perfusion and microenvironment of human tumors, pp 113-120 in Medical Radiology: Diagnostic Imaging and Radiation Oncology (M. MOLLS and P. VAUPEL, eds.). Springer Verlag, Berlin (1998).
6. R. J. GILLIES, R. MARTINEZ-ZAGUILAN, E. P. PETERSON and R. PERONA, Role of intracellular pH in mammalian cell proliferation, Cell Physiol. Biochem. 2, 159-179 (1992).
7. 31P MRS as a method of measuring pH in rat tumours, NMR Biomed. 5, 351-359 (1992).
8. M. STUBBS, L. M. RODRIGUES, F. A. HOWE, J. WANG, K. S. JEONG, R. L. VEECH and J. R. GRIFFITHS, The metabolic consequences of a reversed pH gradient in rat tumours, Cancer Res. 54, 4011-4016 (1994).
9. T. FRENZEL, S. KOHLER, H. BAUER, U. NIEDBALLA and H. J. WEINMANN, Non-invasive in vivo measurements using a fluorinated pH probe and fluorine-19 magnetic resonance spectroscopy, Invest. Radiol. 29, S220-S222 (1994).
10. 31PMRS measurements of extracellular pH of tumors using 3-aminopropylphosphonate, Am. J. Physiol. 267, C195-C203 (1994).
11. 1H NMR probes for the determination of intracellular pH, extracellular pH and cell volume, Bioorg. and Med. Chem. 2, 305-314 (1994).
12. 1H MRSI, Proc. Int. Soc. Magn. Reson. 6, 1642 (1998).
13. L. E. GERWECK and K. SEETHARAMAN, Cellular pH gradient in tumor versus normal tissue: potential exploitation for the treatment of cancer, Cancer Res. 56, 1194-1198 (1996).
14. M. KRAUS, T. SEVERIN and B. WOLF, Relevance of microenvironmental pH for self-organised tumor growth and invasion, Anticancer Res. 14, 1573-1584 (1994).
15. R. A. GATENBY and E. T. GAWLINSKI, A reaction-diffusion model of cancer invasion, Cancer Res. 56, 5745-5753 (1996).
16. P. J. M. MCSHEEHY, S. P. ROBINSON, A. C. E. OJUGO, M. B. CANNELL, M. O. LEACH, I. R. JUDSON and J. R. GRIFFITHS, Carbogen breathing increases 5-fluorouracil uptake and cytotoxicity in hypoxic murine RIF-1 tumors: a magnetic resonance study in vivo, Cancer. Res. 58, 1185-1194 (1998).
17. R. J. ORDIDGE, A. CONNELLY and J. A. B. LOHMAN, Image-selected in vivo spectroscopy (ISIS). A new technique for spatially selective NMR spectroscopy, J. Magn. Reson. 66, 283-294 (1986).
18. 31P MRS, Soc. Magn. Reson. 3, 1337 (1994).
19. 31P MRS in murine tumours, Brit. J. Cancer 72, 905-911 (1995).
20. 31P NMR signals using the variable projection method and prior knowledge, Magn. Reson. Med. 6, 92-96 (1988).
21. R. C. POOLE and A. P. HALESTRAP, Transport of lactate and other monocarboxylates across mammalian plasma membranes. Am. J. Physiol. 264, (Cell Physiol. 33) C761-C782 (1993).
22. I.-Y. LEE, R. C. STRUNK and E. L. COE, Coordination among rate limiting steps of glycolysis and respiration in intact ascites tumor cells, J. Biol. Chem. 242, 2021-2028 (1967).
23. + ATP'ases are functionally expressed in plasma membranes of human tumor cells, Am. J. Physiol. 265, C1015-C1029 (1993).
24. I. F. TANNOCK and D. ROTIN, Acid pH in tumors and its potential for therapeutic exploitation, Cancer Res. 49, 4373-4384 (1989).
25. A. H. LEE and I. F. TANNOCK, Heterogeneity of intracellular pH and of mechanisms that regulate intracellular pH in populations of cultured cells, Cancer Res. 58, 1901-1908 (1998).
26. I. H. MADSHUS, Regulation of intracellular pH in eukaryotic cells, Biochem J. 250, 1-8 (1988).
27. 15O perfusion measurements in the RIF-1 murine tumor in vivo, Radiation Research 106, 122-131 (1986).
28. T. L. SPENCER and A. L. LEHNINGER, L-Lactate transport in Ehrlich ascitestumour cells, Biochem. J. 154, 405-414 (1976).
29. K. NEWELL, A. FRANCHI, J. POUYSSEGUR and I. TANNOCK, Studies with glycolysis-deficient cells suggest that production of lactic acid is not the only cause of tumor acidity, Proc. Natl. Acad. Sci. USA 90, 1127-1131 (1993).
30. C. S. OWEN, Dependence of proton generation on aerobic or anaerobic metbolism and implications for tumour pH, Int. J Hyperthermia 12, 495-499 (1996).
31. M. TERPSTRA, W. B. HIGH, Y. LUO, R. A. DE GRAAF, H. MERKLE and M. GARWOOD, Relationships amongst lactate concentration, blood flow and histopathological profiles in rat C6 glioma, NMR in Biomed. 9, 185-194 (1996).
32. 2H NMR spectroscopy, Proc. Soc. Magn. Reson. 10, 984 (1991).
33. 31P Nuclear magnetic resonance evidence for the regulation of intracellular pH by Ehrlich ascites tumor cells, J. Cell. Biol. 95, 24-28 (1982).
34. P. VAUPEL, Pathophysiological mechanisms of hyperthermia in cancer therapy, pp. 73-134 in Biological Basis of Oncologic Thermotherapy (M. GAUTHERIE, ed.) Springer Verlag, Heidelberg, Germany (1990).
35. J. FOLKMAN, Tumor angiogenesis and tissue factor, Nature Med. 2, 167-168 (1996).
36. P. BRAUNSCHWEIGER, Effect of cyclophosphamide on the pathophysiology of RIF-1 solid tumors, Cancer Res. 48, 4206-4210 (1988).
37. K. W. NEWELL, P. WOOD, I. STRATFORD and I. TANNOCK, Effects of agents which inhibit the regulation of intracellular pH on murine solid tumors, Brit. J. Cancer 66, 311-317 (1992).
38. R. P. MAIDORN, E. J. CRAGOE JR. and I. F. TANNOCK, Therapeutic potential of analogues of amiloride: inhibition of the regulation of intracellular pH as a posssible mechanism of tumor selective therapy, Brit. J. Cancer 67, 297-303 (1993).
39. 1 increases the extracellular pH of pituitary tumors and inhibits their growth in vivo, Proc. Am. Assoc. Cancer Res. 39, 1539 (1998).
40. S. V. KOZIN and L. E. GERWECK, Cytotoxicity of weak electrolytes after the adaptation of cells to low pH: role of the transmembrane pH gradient, Brit. J. Cancer 77, 1580-1585 (1998).
41. L. D. SKARSGARD, M. W. SKARCHUK, A. VINCZAN, J. KRISTL and D. J. CHAPLIN, The cytotoxocity of melphalan and its relationship to pH, hypoxia and drug uptake, Anticancer Res. 15, 219-224 (1995).
42. A. S. E. OJUGO, P. M. J. MCSHEEHY, M. STUBBS, G. ALDER, C. L. BASHFORD, R. J. MAXWELL, M. O. LEACH, I. R. JUDSON and J. R. GRIFFITHS, Influence of pH on the uptake of 5-fluorouracil into isolated tumour cells, Brit. J. Cancer 77, 873-879 (1998).
43. M. YAMAGATA, K. HASUDA, T. STAMATO and I. F. TANNOCK, The contribution of lactic acid to acidification of tumours: studies of variant cells lacking lactate dehydrogenase, Brit. J. Cancer 77, 1726-1731 (1998).